The estimated Net Worth of Gabriel Schmergel is at least $7.4 Million dollars as of 16 February 2012. Gabriel Schmergel owns over 12,294 units of Revvity stock worth over $6,952,679 and over the last 21 years Gabriel sold PKI stock worth over $445,537.
Gabriel has made over 7 trades of the Revvity stock since 2006, according to the Form 4 filled with the SEC. Most recently Gabriel exercised 12,294 units of PKI stock worth $256,084 on 16 February 2012.
The largest trade Gabriel's ever made was exercising 20,000 units of Revvity stock on 11 August 2008 worth over $317,600. On average, Gabriel trades about 5,993 units every 169 days since 2004. As of 16 February 2012 Gabriel still owns at least 60,306 units of Revvity stock.
You can see the complete history of Gabriel Schmergel stock trades at the bottom of the page.
Gabriel's mailing address filed with the SEC is 45 WILLIAM STREET, , WELLESLEY, MA, 02481.
Over the last 26 years, insiders at Revvity have traded over $204,298,889 worth of Revvity stock and bought 55,200 units worth $1,110,570 . The most active insiders traders include Alexis P Michas, Gregory L Summe, and Robert F Friel. On average, Revvity executives and independent directors trade stock every 25 days with the average trade being worth of $6,184,617. The most recent stock trade was executed by Andrew Okun on 13 April 2023, trading 2,435 units of PKI stock currently worth $332,402.
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.
Revvity executives and other stock owners filed with the SEC include: